Javascript must be enabled to continue!
Radium brachytherapy a predecessor to modern brachytherapy: A historical review from an Indian perspective
View through CrossRef
ABSTRACT
The discovery of X-rays and radium formed the basis of radiation therapy. Radium was the first radioisotope used in medicine in the form of surface mold, intracavitary, and interstitial implants, which is a highly conformal form of radiation therapy. India was one of the early users of radium, and Colonel Vaughan J.C. used 10 mg of radium at Ranchi. Major V Arthur Ponnaiah, was appointed as a radium safety officer, Barnard Institute of Radiology, Chennai, the first in India. The methods, Sievert integral, Manchester system, and Patterson-Parker rules, along with milligram-hour and millicurie-destroyed per square cm, were used in dosimetry. K Munjunath Rai (Chennai), P. K. Haldar (Agra), J. P. Sinha (Patna), and M.L. Aggarwal (Amritsar) were the pioneers of earlier radium applications in India. Y. Siddique had an exclusive radiation therapy training and was awarded by the Faculty of Radiologists (Present FRCR), London. Tata Memorial Hospital (TMH) established the first Radon plant in India under the physicist Ramaiah Naidu. Due to its long half-life, loss of sources, chances of leakage of radioactive material, and bent needles, radium was withdrawn from hospitals and replaced by a Manual Cs-137 kit, supplied by the Bhabha Atomic Research Centre (BARC). Later, Iridium-192 wires were used for manual interstitial implants, followed by remote after-loading systems. Establishment of the specialty of radiology and taking over radium from the purview of surgeons were a challenge in many hospitals. The journey of radium application was an early milestone of cancer therapy management, which was built over the sacrifices of many Indian surgeons, radiologists, and physicists. This paper reviewed the use of radium, from information collected from the individuals and hospitals who had the opportunity to work with them.
Ovid Technologies (Wolters Kluwer Health)
Title: Radium brachytherapy a predecessor to modern brachytherapy: A historical review from an Indian perspective
Description:
ABSTRACT
The discovery of X-rays and radium formed the basis of radiation therapy.
Radium was the first radioisotope used in medicine in the form of surface mold, intracavitary, and interstitial implants, which is a highly conformal form of radiation therapy.
India was one of the early users of radium, and Colonel Vaughan J.
C.
used 10 mg of radium at Ranchi.
Major V Arthur Ponnaiah, was appointed as a radium safety officer, Barnard Institute of Radiology, Chennai, the first in India.
The methods, Sievert integral, Manchester system, and Patterson-Parker rules, along with milligram-hour and millicurie-destroyed per square cm, were used in dosimetry.
K Munjunath Rai (Chennai), P.
K.
Haldar (Agra), J.
P.
Sinha (Patna), and M.
L.
Aggarwal (Amritsar) were the pioneers of earlier radium applications in India.
Y.
Siddique had an exclusive radiation therapy training and was awarded by the Faculty of Radiologists (Present FRCR), London.
Tata Memorial Hospital (TMH) established the first Radon plant in India under the physicist Ramaiah Naidu.
Due to its long half-life, loss of sources, chances of leakage of radioactive material, and bent needles, radium was withdrawn from hospitals and replaced by a Manual Cs-137 kit, supplied by the Bhabha Atomic Research Centre (BARC).
Later, Iridium-192 wires were used for manual interstitial implants, followed by remote after-loading systems.
Establishment of the specialty of radiology and taking over radium from the purview of surgeons were a challenge in many hospitals.
The journey of radium application was an early milestone of cancer therapy management, which was built over the sacrifices of many Indian surgeons, radiologists, and physicists.
This paper reviewed the use of radium, from information collected from the individuals and hospitals who had the opportunity to work with them.
Related Results
Re-treatment of metastatic castration-resistant prostate cancer patients with radium-223 therapy in daily practice.
Re-treatment of metastatic castration-resistant prostate cancer patients with radium-223 therapy in daily practice.
183
Background:
Radium-223 is a therapeutic option for metastatic castration-resistant prostate cancer (mCRPC) patients with symptomat...
Radium: Radionuclides
Radium: Radionuclides
AbstractThis article describes (1) the occurrence, chemistry, and bioavailability of radium (Ra) in terrestrial and aquatic environments, and its analysis in environmental samples,...
Radium: Radionuclides
Radium: Radionuclides
AbstractThis article describes (1) the occurrence, chemistry, and bioavailability of radium (Ra) in terrestrial and aquatic environments, and its analysis in environmental samples,...
P4-16-04: An Open-Label, Phase IIa, Non-Randomized Study of Radium-223 in Breast Cancer Patients with Bone Dominant Disease No Longer Considered Suitable for Endocrine Therapy.
P4-16-04: An Open-Label, Phase IIa, Non-Randomized Study of Radium-223 in Breast Cancer Patients with Bone Dominant Disease No Longer Considered Suitable for Endocrine Therapy.
Abstract
Background
Radium-223 (Alpharadin™) is a 1st-in-class alpha-pharmaceutical. It targets bone metastases (mets) with high-energy alpha-radiatio...
Nasopharyngeal intracavitary brachytherapy
Nasopharyngeal intracavitary brachytherapy
AbstractBACKGROUNDLocally persistent nasopharyngeal carcinoma (NPC) carries an increased risk of local failure if additional treatment is not given. It has been shown that intracav...
TH‐SAM‐BRB‐01: HDR and LDR Brachytherapy: Everything You Need to Know
TH‐SAM‐BRB‐01: HDR and LDR Brachytherapy: Everything You Need to Know
The development of Brachytherapy began about 1899 following the purification of radium by Pierre and Marie Curie and has been developing rapidly and continually since. The focus of...
RADT-01 A COMPREHENSIVE REVIEW OF THE UTILITY OF BRACHYTHERAPY IN THE MANAGEMENT OF BRAIN METASTASIS
RADT-01 A COMPREHENSIVE REVIEW OF THE UTILITY OF BRACHYTHERAPY IN THE MANAGEMENT OF BRAIN METASTASIS
Abstract
PURPOSE
This literature review investigates the current applications of brachytherapy in treating brain metastases (BMs...
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
BACKGROUND: Infravesical obstruction in patients with localized prostate cancer caused by concomitant benign prostatic hyperplasia substantially limits the feasibility of low-dose-...

